Purpose. Bayesian random-effects meta-analyses require the analyst to specify the prior distribution for between-study variance of the treatment effect. We assessed the sensitivity of prediction and other outputs of the meta-analysis to the choice of this prior. Methods. We reana-lyzed 7 published meta-analyses (5–14 trials) with rare (event rates \5%), moderate (15%–50%), and frequent binary outcomes (.50%). We examined 10 noninforma-tive priors: inverse gamma on between-study variance (t2), 2 uniforms on each of the between-study standard deviation (t) and t2, uniform shrinkage on t2, DuMouchel shrinkage on t, half-normal on t2, and half-normal priors on t with large and small variances. For each analysis, we calculated the posterior dist...
Meta-analysis methods are used to synthesize results of multiple studies on the same topic. The most...
Historical information is always relevant for clinical trial design. Additionally, if incorporated i...
OBJECTIVES: Findings from nonrandomized studies on safety or efficacy of treatment in patient subgro...
Multivariate random-effects meta-analysis allows the joint synthesis of correlated results from mult...
In designing a randomized controlled trial, it has been argued that trialists should consider existi...
Contains fulltext : 232638.pdf (Publisher’s version ) (Open Access)In rare disease...
A previous investigation by Lambert et al., which used computer simulation to examine the influence ...
Meta-analysis (MA) combines multiple studies to estimate a quantity of interest. Some existing MA mo...
A previous investigation by Lambert et al., which used computer simulation to examine the influence ...
Numerous meta-analyses in healthcare research combine results from only a small number of studies, f...
Numerous meta-analyses in healthcare research combine results from only a small number of studies, f...
In Bayesian meta-analysis, the specification of prior probabilities for the between-study heterogene...
Background: Pairwise and network meta-analyses using fixed effect and random effects models are comm...
Bayesian meta-analysis is an increasingly important component of clinical research, with multivariat...
The most crucial part in Bayesian analysis is the choice of prior distribution. Improper priors are ...
Meta-analysis methods are used to synthesize results of multiple studies on the same topic. The most...
Historical information is always relevant for clinical trial design. Additionally, if incorporated i...
OBJECTIVES: Findings from nonrandomized studies on safety or efficacy of treatment in patient subgro...
Multivariate random-effects meta-analysis allows the joint synthesis of correlated results from mult...
In designing a randomized controlled trial, it has been argued that trialists should consider existi...
Contains fulltext : 232638.pdf (Publisher’s version ) (Open Access)In rare disease...
A previous investigation by Lambert et al., which used computer simulation to examine the influence ...
Meta-analysis (MA) combines multiple studies to estimate a quantity of interest. Some existing MA mo...
A previous investigation by Lambert et al., which used computer simulation to examine the influence ...
Numerous meta-analyses in healthcare research combine results from only a small number of studies, f...
Numerous meta-analyses in healthcare research combine results from only a small number of studies, f...
In Bayesian meta-analysis, the specification of prior probabilities for the between-study heterogene...
Background: Pairwise and network meta-analyses using fixed effect and random effects models are comm...
Bayesian meta-analysis is an increasingly important component of clinical research, with multivariat...
The most crucial part in Bayesian analysis is the choice of prior distribution. Improper priors are ...
Meta-analysis methods are used to synthesize results of multiple studies on the same topic. The most...
Historical information is always relevant for clinical trial design. Additionally, if incorporated i...
OBJECTIVES: Findings from nonrandomized studies on safety or efficacy of treatment in patient subgro...